The global diabetes dietary supplement market is estimated to exhibit a CAGR of around 4.2% during the forecast period. The market growth is attributed to the increasing prevalence of diabetes coupled with the growing geriatric population across the globe. In addition, increasing awareness among people about supplements tends to increase the demand and hence drive the growth of the global diabetes dietary supplement market. Furthermore, the rising prevalence of obesity and diabetes among children and adolescents as a result of a lack of physical activity is creating demand for better therapeutic solutions and hence fueling market growth. Growing research and development (R&D) to develop innovative diabetic food supplements, as well as the presence of a broad product portfolio that caters to the needs of a diverse consumer base, are also propelling the market growth. Additionally, producers and vendors are embracing online retail systems to give a large product selection to consumers, owing to growing digitization and thriving e-commerce business.
Type 2 diabetes accounted for a major portion of the market
Chronic conditions are more common in the geriatric population. The type 2 diabetes segment is expected to account for a major portion of the global diabetes dietary supplements market. The segmental growth is attributed to the high prevalence of type 2 diabetes among adults. According to the National Health Interview Survey in 2016 and 2017, Type 2 diabetes was widespread among older men, adults, and those with lower family income, lower educational level, and greater body mass index (BMI) in the US. Owing to the development of scientifically made vitamin supplements by leading market players and increased awareness of vitamin-based diabetic supplements among patients, the vitamins segment is expected to lead the global market in the coming years. The rising need for energy and weight management among sportsmen and working professionals is also expected to fuel the segmental market growth.
Growing elderly population – a major factor for market growth in the Asia Pacific region
The Asia Pacific diabetic dietary supplements market is driven by the growing elderly population, increasing number of people with diabetes, rising healthcare expenditures, rising health awareness among people, and the presence of a significant number of industry players. Additionally, North America provides enormous growth potential in the diabetes supplements market owing to the advancements in the pharmaceutical & nutraceutical sector, increased spending in R&D efforts and an increasing number of diabetic patients. North America-based industry players are also focused on a variety of strategies to strengthen their market position which is also propelling the regional industry growth. Further, changing consumer perceptions of dietary supplement products in European countries such as Belgium, Austria, Denmark, and Greece are driving the adoption of nutritional supplements across Europe. The region’s need for specialist supplements is increasing, and companies in the region are increasingly relying on e-commerce platforms to expand their reach both regionally and globally.
Market structure and competitive landscape
The market is fiercely competitive, with both public and private businesses focused on product innovation and research & development. Companies in the global diabetic supplements market are expected to collaborate with researchers to develop a variety of products to meet customer demand on a global scale. These factors are contributing to the rapid expansion of the market, resulting in potential benefits for market players. Some of the prominent players in the market are Abbott Laboratories Inc., Aksuvital Natural Products Co., Arkopharma, Bionova, Caelus Health, CuraLife Global, Danone SA, Dr. Reddy’s Laboratories Ltd., Glucose Health Inc., Hexagon Nutrition Pvt. Ltd., La Grande P Ltd. (La Nutraceuticals), Lysulin Inc., Nature’s Sunshine Products Inc., Nestlé Health Science, and Nutricia among others.
- In December 2021, Danone India (Danone SA) launched Protinex Diabetes Care with an aim to address the nutritional requirements of Indians with diabetes.
- In November 2019, India-based Dr. Reddy’s Laboratories Ltd. announced the launch of Celevida in India to help manage blood glucose levels among Indian patients.
Key Market Segmentation
The RationalStat has segmented the global Diabetes Dietary Supplements Market on the basis of type, diabetes type, dosage form, distribution channel, and region.
- By Type
- Others (Dietary Fibers etc.)
- By Diabetes Type
- Type 1 Diabetes
- Type 2 Diabetes
- By Dosage Form
- Others (Solutions etc.)
- Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- By Region
- North America
- Latin America
- Rest of Latin America
- Western Europe
- Rest of Western Europe
- Eastern Europe
- Rest of Eastern Europe
- Asia Pacific
- South Korea
- ASEAN (Indonesia, Vietnam, Malaysia, etc.)
- Rest of Asia Pacific
- Middle East & Africa
- South Africa
- Rest of the Middle East & Africa
- North America
RationalStat has developed a state-of-the-art research methodology to crunch numbers and provide the best possible real-time insights to clients. We combine a varied range of industry experience, data analytics, and experts’ viewpoint to create a research methodology for market sizing and forecasting.
RationalStat combines a mix of secondary sources as well as primary research to assess the market size and develop a forecast. Key steps involved in accurately deriving the market numbers are:
- Defining the problem by understanding the type of market and data required by the client.
- Data gathering and collection through relevant paid databases, publicly available sources, company reports, annual reports, surveys, and interviews.
- Formulating a hypothesis to create market numbers, forecast, influencing factors, and their relevance.
- Evaluating and analyzing the data by referring to data sources utilized and leveraged.
- Validating, interpreting, and finalizing the data by combining the details gathered from primary and secondary sources with the help of experienced analysts.
- Annual reports, company filings, investor presentations, product catalogs, and company documents
- Industry and market-related documents available in the public domain
- Paid database including Bloomberg, Factiva, S&P Capital IQ, FactSet, Refinitiv Eikon, ICIS, EUWID, Thomson Reuters, among others
- Whitepapers, research papers, and industry blogs.
Why Buy this Report?
The report is intended for dietary supplement manufacturers and suppliers, nutraceutical companies, healthcare facilities, government organizations, food & beverage industry, regulatory agencies, and market research firms, among others. The report provides an in-depth analysis of market size, consumption pattern, ongoing market trends and challenges, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights to clients to find the right answers to their business questions.
Frequently Asked Questions (FAQs)
The global diabetic dietary supplements market is expected to grow at a CAGR of approximately 4.2% during the forecast period 2022-2028.
Asia Pacific holds a prominent share of the global diabetic dietary supplements market.
The global market for diabetic dietary supplements was US$ 13.5 Billion in 2021.
The growing geriatric population and prevalence of obesity and diabetes among children are the major factors augmenting the growth of the global diabetic dietary supplements market.
Major companies operating in the global diabetic dietary supplements market are Abbott Laboratories Inc., Aksuvital Natural Products Co., Arkopharma, Bionova, Caelus Health, CuraLife Global, Danone SA, Dr. Reddy’s Laboratories Ltd., Glucose Health Inc., Hexagon Nutrition Pvt. Ltd., La Grande P Ltd. (La Nutraceuticals), Lysulin Inc., Nature’s Sunshine Products Inc., Nestlé Health Science, and Nutricia among others.